<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03741153</url>
  </required_header>
  <id_info>
    <org_study_id>PXSDM</org_study_id>
    <nct_id>NCT03741153</nct_id>
  </id_info>
  <brief_title>Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus</brief_title>
  <official_title>The Possible Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus in an Egyptian Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pseudoexfoliation syndrome (PEX) is characterized by the deposition of a distinctive
      fibrillar material in the anterior segment of the eye and was first described in 1917 by
      Lindberg. It is frequently associated with open angle glaucoma, known as pseudoexfoliation
      glaucoma, which is one of the most common identifiable forms of secondary open angle glaucoma
      worldwide. Despite extensive research, the exactchemical nature of the fibrillar material is
      unknown. It is believed to be secreted multifocally in the iris pigment epithelium, the
      ciliary epithelium, and the peripheral anterior lens epithelium.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2019</start_date>
  <completion_date type="Anticipated">March 14, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the percentage of diabetic patients with pseudo-exfoliation syndrome</measure>
    <time_frame>10 minutes</time_frame>
    <description>slit lamp examination of all diabetic patients to get the percentage of those with pseudo-exfoliation syndrome</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lens Diseases</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <description>includes patients who will be diagnosed with Pseudoexfoliation syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>age matched controls who do not have Pseudoexfoliation syndrome</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>slit lamp</intervention_name>
    <description>Presence of white grayish exfoliation material on the anterior lens capsule and / or the pupillary margin.
Poor pupillary dilatation due to atrophy of the dilator pupillae muscle.
The presence of pseudoexfoliative material (PXF)in cilliary processes and zonules.
presence of PXF material scattered on corneal endothelium.
Flecks of the exfoliative material on the anterior chamber which leads to glaucoma.</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients who will be diagnosed with pseudo-exfolian syndrome
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Phakic patients presenting to Ophthalmology outpatient clinic Of Assiut University
             Hospital.

        Exclusion Criteria:

          -  Patients with previous intraocular surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 11, 2018</study_first_submitted>
  <study_first_submitted_qc>November 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2018</study_first_posted>
  <last_update_submitted>November 11, 2018</last_update_submitted>
  <last_update_submitted_qc>November 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>gehad salah eldin galal</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Exfoliation Syndrome</mesh_term>
    <mesh_term>Lens Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

